NSEOutcome of Board Meeting6d ago · 13 Nov 2026, 04:00 pm
Outcome of Board Meeting
Manipal Health Enterprises Limited · MANIPALHOS
✦ AI SummaryResults
Manipal Health Enterprises Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, which were reviewed by Price Waterhouse Chartered Accountants LLP. The results were approved by the Board of Directors and will be uploaded on the company's website.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Manipal Health Enterprises Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Attachments (1)
📄pdf
Download →
9632000477_13112026155758_FinalOutcome_OCR_Signed.pdf
View document text
manipalhospitals '
LIFE'S ON El
Date: November 13, 2026
National Stock Exchange of India Limited, BSE Limited,
Exchange Plaza, C-1, Block G, 20th Floor, P.J. Towers,
Bandra Kurla Complex, Bandra (E), Dalal Street,
Mumbai – 400 051 Mumbai - 400001.
NSE Scrip Symbol: MANIPALHOS BSE Scrip Code: 544847
Subject: Outcome of the Board Meeting of Manipal Health Enterprises Limited (“the Company”)
Ref.: Disclosure under Reg. 33 and Reg. 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“Listing Regulations”)
Dear Sir/Ma’am,
We would like to inform you that the Board of Directors at its meeting held today i.e., November 13, 2026,
which commenced at 3:26 P.M. (IST) and concluded at 3:38 PM (IST) have inter alia considered, and
approved, the Unaudited financial results (both standalone and consolidated) of the Company for the
quarter and half year ended September 30, 2026, along with Limited Review Report with unmodified
opinion issued by the Statutory Auditors of Company pursuant to applicable provisions of the Companies
Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including
amendments, if any. Copies of the same are enclosed herewith.
The above announcements will also be uploaded on the website of the Company and can be accessed using
the link: https://www.manipalhospitals.com/mhel-financial-reports#board-meeting-outcome
This intimation is being submitted for your information and records.
Thank you.
For Manipal Health Enterprises Limited
(formerly Manipal Health Enterprises Private Limited)
Sathish K R
Company Secretary and Compliance Officer
Membership No.: A15203
Manipal Health Enterprises limited
(Formerly known as Manipal Health Enterprises Private Limited)
GIN: L85110KA2010PLC052540
Regd. Off. The Annexe, #98/2, Rustom Bagh, HAL Airport Road, Bengaluru 560 017, Karno.takn
P 91 80 4936 0300Einfo@manipalhospitals.comwww.manipalhospitals.com
MHE-Public
Price Waterhouse Chartered Accountants LLP
Review Report
The Board of Directors
Manipal Health Enterprises Limited (formerly known as Manipal Health Enterprises Private Limited)
The Annexe, #98/2, Rustom Bagh, Off HAL Airport Road,
Bangalore, Karnataka 560 017
1. We have reviewed the standalone unaudited financial results of Manipal Health Enterprises
Limited (formerly known as Manipal Health Enterprises Private Limited) (the "Company") for the
quarter ended September 30, 2026 and the year to date results for the period April 1, 2026 to
September 30, 2026, and the Statement of Assets and Liabilities as on that date and the
Statement of Cash Flows for the six months ended on that date which are included in the
accompanying 'Statement of Standalone Unaudited Financial Results for the quarter and six
months ended September 30, 2026', the 'Statement of Standalone Unaudited Assets and
Liabilities as at September 30, 2026' and the 'Statement of Standalone Unaudited Cash Flows for
six months ended September 30, 2026' together with the notes thereon (the "Statement"). The
Statement has been prepared by the Company pursuant to Regulation 33 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing
Regulations, 2015"), which has been initialled by us for identification purposes. The Statement is
the responsibility of the Company's Management and has been approved by the Board of
Directors. Our responsibility is to issue a report on the Statement based on our review.
2. We conducted our review of the Statement in accordance with the Standard on Review
Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the
Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This
Standard requires that we plan and perform the review to obtain moderate assurance as to
whether the Statement is free of material misstatement.
3. A review is limited primarily to inquiries of company personnel and analytical procedures applied
to financial data and thus provides less assurance than an audit. We have not performed an audit
and accordingly, we do not express an audit opinion.
4. Based on our review conducted as above, nothing has come to our attention that causes us to
believe that the Statement has not been prepared in all material respects in accordance with the
recognition and measurement principles laid down in the aforesaid Indian Accounting Standard
and other accounting principles generally accepted in India and has not disclosed the information
required to be disclosed in terms of Regulation 33 of the Listing Regulations, 2015 including the
manner in which it is to be disclosed, or that it contains any material misstatement.
Price Waterhouse Chartered Accountants LLP, 5th Floor, Tower 'D', The Millenia, 1 & 2 Murphy Road, Ulsoor
Bengaluru -560 008
T:+91 (80) 40794190
Registered office and Head office: 11-A, Vishnu Digamber Marg, Sucheta Bhawan, New Delhi -110002
Price Waterhouse (a Partnership Firm) converted into Price Waterhouse Chartered Accountants LLP (a Limited Liability Partnership with LLP identity no: LLPIN AAC-5001)
with effect from July 25, 2014. Post its conversion to Price Waterhouse Chartered Accountants LLP, its ICAI registration number is 012754N/N500016 (ICAI registration
number before conversion was 012754N)
Price Waterhouse Chartered Accountants LLP
5. (a) The standalone financial statements of the Company for the year ended March 31, 2026 were
audited by another firm of Chartered Accountants, who issued an unmodified opinion vide
their report dated July 15, 2026.
(b) The standalone financial results of the Company for the quarter ended June 30, 2026 were
reviewed by another firm of chartered accountants who, vide their report dated August 20,
2026, expressed an unmodified conclusion on those standalone financial results.
(c) We were neither engaged to review, nor have we reviewed the comparative figures for the
statement of standalone cash flows for the period April 1, 2025 to September 30, 2025, and
the standalone financial results for the corresponding period for the quarter ended September
30, 2025 and year to date results for the period April 1, 2025 to September 30, 2025, and
accordingly, we do not express any conclusion on the standalone cash flows presented in the
Statement for the period from April 1, 2025 to September 30, 2025 and the standalone
financial results in the Statement for the quarter ended September 30, 2025 and year to date
results for the period April 1, 2025 to September 30, 2025. As set out in Note 3 to the
Statement, these figures have been furnished by the Management.
Our conclusion is not modified in respect of these matters.
For Price Waterhouse Chartered Accountants LLP
Firm Registration Number: 012754N/N500016
Abhishek Rara
Partner
Membership Number: 077779
UDIN: 26077779DUULWO5049
Place: Bengaluru
Date: November 13, 2026
Manipal Health Enterprises Limited (formerly lmown as Manipal Health Enterprises Private Limited)
Registered Office and Corporate Office: The Annexe, #98/2, Rustom Bagh, Off HAL Airport Road, Bane:alore, Kamataka 560 017
CIN:L85110KA2010PLC052540, Tel: +91 80 4936 0300, Email: leealcs@manipalhospitals.com, Website: www.manipalhospitals.com
STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED SEPTEMBER 30, 2026
({ in crores except per share data)
Quarter Ended Six Months Ended Year Ended
Particulars September 30, 2026 June 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025 March 31, 2026
(Unaudited) (Unaudited) fUnaudited)3 (Unaudited) (Unaudited)3 (Audited)
Income
I Revenue from Operations 1,151.13 1,048.30 901.64 2,199.43 1,719.66 3,584.13
II Other Income 98.63 40.87 26.64 139.50 61.16 117.44
III Total Income (l+II) 1,249.76 1,089.17 928.28 2,338.93 1,780.82 3,701.57
IV Expenses
Purchase of medical consumables and pharmacy items 226.02 214.33 181.30 440.35 343.39 717.88
Changes in inventories of medical consumables and pharmacy ite
[Showing first 8,000 characters — download PDF for full document]